Top-News

Antares Pharma News

Aktie
WKN:  903128 ISIN:  US0366421065 US-Symbol:  ATRS
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
168,80 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 21.06.2021

Antares Pharma News

12.05.22 - PR Newswire
Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma
Hart-​Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma PR Newswire
06.05.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds SAIL, SAVE, EXTN and ATRS Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds SAIL, SAVE, EXTN and ATRS Shareholders About Its Ongoing Investigations PR Newswire
03.05.22 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, SBOW, SRRA, ATRS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, SBOW, SRRA, ATRS PR Newswire
28.04.22 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PLAN, WAVD, SRRA, ATRS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PLAN, WAVD, SRRA, ATRS PR Newswire
27.04.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds MSP, SAIL, SAVE, and ATRS Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds MSP, SAIL, SAVE, and ATRS Shareholders About Its Ongoing Investigations PR Newswire
20.04.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Reminds ATRS, SRRA, HBP, and EMCF Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: Weiss Law Reminds ATRS, SRRA, HBP, and EMCF Shareholders About Its Ongoing Investigations PR Newswire
18.04.22 - PR Newswire
Investor Alert - The M&A Class Action Firm is Investigating the Merger - ATRS, SRRA, SAIL, MSP, CDK, VWTR
Investor Alert - The M&A Class Action Firm is Investigating the Merger - ATRS, SRRA, SAIL, MSP, CDK, VWTR PR Newswire
13.04.22 - PR Newswire
SHAREHOLDER ALERT: Weiss Law Investigates Antares Pharma, Inc.
SHAREHOLDER ALERT: Weiss Law Investigates Antares Pharma, Inc. PR Newswire
13.04.22 - Der Aktionär
Übernahme‑Doppelschlag am Mittwoch – Biotech‑Branche vor großem Comeback?
13.04.22 - PR Newswire
Thinking about buying stock in Antares Pharma, Celsion Corp, American Airlines, Kaleido Biosciences, or CTI BioPharma?
Thinking about buying stock in Antares Pharma, Celsion Corp, American Airlines, Kaleido Biosciences, or CTI BioPharma? PR Newswire
13.04.22 - PR Newswire
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader PR Newswire
05.09.21 - The Motley Fool
1.000 Euro auf der hohen Kante? Diese 2 günstigen Biopharma-Aktien könnten sich lohnen
Wichtige Punkte vorab:
01.01.21 - The Motley Fool
3 Top-Aktien, die zu unter 5 Dollar pro Aktie gehandelt werden
Nicht alle Investoren haben riesige Mittel zur Verfügung, um Aktien zu kaufen. Daher suchen sie nach Unternehmen, deren Aktien zu relativ niedrigen Preisen gehandelt werden. ...
14.11.17 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS
SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS ...
03.11.17 - PR Newswire
ANTARES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Antares Pharma, Inc. To Contact The Firm
ANTARES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Antares Pharma, Inc. To Contact The Firm ...
31.10.17 - PR Newswire
Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of a Securities Class Action Against Antares Pharma, Inc. (ATRS)
Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of a Securities Class Action Against Antares Pharma, Inc. (ATRS) PR Newswire
24.10.17 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Antares Pharma, Inc. (ATRS) & Lead Plaintiff Deadline: December 22, 2017
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Antares Pharma, Inc. (ATRS) & Lead Plaintiff Deadline: December 22, 2017 ...
18.10.17 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Antares Pharma, Inc. - ATRS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Antares Pharma, Inc. - ATRS PR Newswire
11.03.14 - PR Newswire
Medac Pharma, Inc. Announces the Issuance of U.S. Patent for Treating Autoimmune Diseases with Concentrated Methotrexate Solutions of More Than 30 mg/ml
Medac Pharma, Inc. Announces the Issuance of U.S. Patent for Treating Autoimmune Diseases with Concentrated Methotrexate Solutions of More Than 30 mg/ml Medac Files ...
20.06.12 - Aktiencheck
Antares Pharma-Aktie: Gewinne in trockene Tücher packen - Global Biotech Investing
Die Experten von "Global Biotech Investing" empfehlen, bei der Aktie von Antares Pharma wenigstens einen Teil der Gewinne in trockene Tücher zu packen. Die Gesellschaft habe ...

Newssuche

Videos

newspaper
17.05.24 -5,31%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »